The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 23, 2010

Filed:

Jun. 15, 2004
Applicants:

Michael Volker, Cologne, DE;

Michael Becka, Ense, DE;

Werner Kroll, Stamford, CT (US);

Andreas Knorr, Erkrath, DE;

Sylvia Unger, Heidelberg, DE;

Mathias Gehrmann, Leverkusen, DE;

Guido Hennig, Krefeld, DE;

Elmar-reinhold Burchardt, Schwerte, DE;

Michael J. Arthur, West Wellow, GB;

Alastair D. Burt, Fairmoor Morphet, GB;

Massimo Pinzani, Scandicci, IT;

Detlef Schuppan, Bubenreuth, DE;

Robert P. Thiel, Oxford, CT (US);

Christoph Petry, Leverkusen, DE;

William Rosenberg, Eastleigh, GB;

Inventors:

Michael Volker, Cologne, DE;

Michael Becka, Ense, DE;

Werner Kroll, Stamford, CT (US);

Andreas Knorr, Erkrath, DE;

Sylvia Unger, Heidelberg, DE;

Mathias Gehrmann, Leverkusen, DE;

Guido Hennig, Krefeld, DE;

Elmar-Reinhold Burchardt, Schwerte, DE;

Michael J. Arthur, West Wellow, GB;

Alastair D. Burt, Fairmoor Morphet, GB;

Massimo Pinzani, Scandicci, IT;

Detlef Schuppan, Bubenreuth, DE;

Robert P. Thiel, Oxford, CT (US);

Christoph Petry, Leverkusen, DE;

William Rosenberg, Eastleigh, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06F 7/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient. The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.


Find Patent Forward Citations

Loading…